ArticleHuman vaccines & immunotherapeutics2025
Efficacy and safety analysis of immune checkpoint inhibitor rechallenge in advanced esophageal squamous cell carcinoma: A retrospective study.
Luni Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.